ProGnosis Biotech participated as an exhibitor at the 11th Panhellenic Congress of the Public Health & Social Medicine Forum, held from 21–23 November 2025 at the Royal Olympic Hotel in Athens. Aligned with this year’s theme, “Innovation, scientific documentation and communication: building a resilient future for public health,” the company presented its latest advancements supporting hygiene monitoring in clinical environments.

As part of the scientific programme, ProGnosis Biotech delivered a satellite lecture titled “From Visual Cleanliness to Scientific Evidence of Hygiene in Hospital Environments: ATP Bioluminescence Technology as a Cleanliness Monitoring Tool for Ensuring Clinical Safety.” The session explored how cutting-edge ATP bioluminescence methods, and especially the ultra- sensitive ATP-FemtoFlow, enable healthcare facilities to transition from subjective visual checks to data-driven hygiene verification.

Throughout the congress, ProGnosis Biotech showcased the role of ATP-FemtoFlow in supporting clinical diagnostics and environmental cleanliness control, emphasizing its relevance for infection prevention and patient safety. The company’s engagement underscored its commitment to equipping public health professionals with reliable, scientifically validated tools designed to strengthen hygiene standards across hospital settings.